Cefotaxime

3 Year Cumulative Antibiogram (Jan 2016 - Dec 2018)
C&W

% of Isolates Susceptible
Streptococcus, Group B

Not tested, reported based on lack of resistance in the published literature

Citrobacter koseri

Note that unlike C. freundii, C. koseri does not have an AmpC beta-lactamase gene

Pseudomonas aeruginosa

Data include patients with cystic fibrosis Cefotaxime, ceftriaxone and SXT are NOT effective for treatment of Pseudomonas aeruginosa infections

Enterococcus faecium

VRE screens excluded

See general susceptibility for more information

Enterococcus faecalis

See general susceptibility for more information

Terms of Use | Feedback
© Copyright 2021 Spectrum Mobile Health Inc., dba Firstline Clinical. All rights reserved.